FIELD: pharmaceutical industry.
SUBSTANCE: group of inventions relates to a means of chondroprotective action and a method of chondroprotective effects on the human musculoskeletal system. A chondroprotective agent that contains glucosamine sulfate, chondroitin sulfate, undenatured type II collagen and excipients as active components in the following ratio of active ingredients per 1 powder sachet: 1,200–1,800 mg of glucosamine sulfate, 960–1,440 mg of chondroitin sulfate, 40–48 mg of undenatured type II collagen. A method to provide chondroprotective effects on the human musculoskeletal system, including the administration of the above-described agent in the amount of 1 powder sachet once a day for a total course of 6–8 weeks.
EFFECT: above-described group of inventions expands the range of chondroprotective agents, the product has an optimized composition of active components, is characterized by increased efficiency of chondroprotective action, while the chemical load on the patient’s body is reduced; the required number of doses per day has been reduced.
8 cl, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
BIOLOGICALLY ACTIVE ADDITIVE TO THE FOOD OF CHONDROPROTECTIVE ACTION | 2016 |
|
RU2648641C2 |
METHOD FOR TREATING PATIENTS FOR DEGENERATIVE LOCOMOTOR APPARATUS DISEASES AND POSTTRAUMATIC PAIN SYNDROMES | 2004 |
|
RU2274472C1 |
METHOD OF TREATING DEGENERATIVELY-DYSTROPHIC DISEASES OF MUSCULOSKELETAL SYSTEM AND POSTTRAUMATIC PAIN SYNDROMES | 2010 |
|
RU2433844C1 |
METHOD OF TREATING DEGENERATIVE-DYSTROPHIC MUSCULOSKELETAL DISEASES AND POSTTRAUMATIC ADHESIVE PROCESSES | 2010 |
|
RU2436584C1 |
METHOD FOR TREATING PATIENTS FOR DEGENERATIVE DYSTROPHY DISEASES OF LOCOMOTOR APPARATUS AND POST-TRAUMATIC COMMISSURE PROCESSES | 2006 |
|
RU2299733C1 |
COMPOSITION FOR TREATING AND PREVENTING OSTEOARTHRITIS, OSTEOPOROSIS AND OSTEOARTHROSIS | 2013 |
|
RU2521227C1 |
COMPOSITION FOR TREATING AND PREVENTING OSTEOARTHRITIS AND OSTEOARTHROSIS | 2011 |
|
RU2509569C2 |
EXTERNAL PREPARATION FOR TREATING ARTHROPATHIES AND SOFT TISSUE CONDITIONS | 2007 |
|
RU2377974C2 |
COMBINATION OF A CHONDROPROTECTIVE AGENT WITH AN NSAID | 2017 |
|
RU2742172C2 |
COMBINED AGENT FOR INTRAARTICULAR ADMINISTRATION | 2017 |
|
RU2737380C2 |
Authors
Dates
2024-02-13—Published
2022-09-09—Filed